Phicrobe
West Lafayette, US · 1 known investors
Phicrobe develops rapid diagnostic tests for detecting E. coli O157:H7 using genetically modified bacteriophage technology that produces light in the presence of the pathogen. The technology enables pathogen detection without specialized equipment or expensive reagents for use in food safety and clinical testing applications.
Investors · 1
Frequently asked questions
- What does Phicrobe do?
- Phicrobe develops rapid diagnostic tests for detecting E. coli O157:H7 using genetically modified bacteriophage technology that produces light in the presence of the pathogen. The technology enables pathogen detection without specialized equipment or expensive reagents for use in food safety and clinical testing applications.
- Who are Phicrobe's investors?
- Phicrobe's investors include Elevate Ventures.
- Where is Phicrobe headquartered?
- Phicrobe is headquartered in West Lafayette, US.